Illumina (ILMN) develops and manufactures various life science tools. According to the company's website the company's mission is to improve human health by unlocking the power of the genome. Let's see what kind of power we can unlock by looking at the charts.
More from Investing
Many tech valuations are now back to 2016 or 2017 levels, and quite a few contrarian indicators point to extreme bearishness.
No one trusts a bounce to last at this point, and they simply are hoping for some relief from the unpleasant action.
APD got a "Buy" recommendation, but my analysis doesn't jibe.
Here's our updated bullish strategy on PXD.